M84.55 Pathological fracture in neoplastic disease, pelvis and femur

Name of the Condition

• Pathological Fracture in Neoplastic Disease, Pelvis and Femur (ICD-10-CM: M84.55)

Summary

This condition describes a bone fracture occurring due to underlying neoplastic (cancerous) disease, specifically involving the pelvis and femur. The fracture results from weakened bone structure caused by the presence of cancer, rather than direct trauma. It is a complication of malignancy affecting the integrity of these skeletal regions, which may involve primary bone tumors or metastatic spread to the pelvis or femur.

Causes

Pathological fractures in neoplastic disease arise when cancerous growths infiltrate or destroy bone tissue in the pelvis or femur, compromising their structural strength. Primary bone cancers (e.g., osteosarcoma) or metastatic tumors (e.g., from breast, lung, or prostate cancer) can erode these bones, leading to spontaneous or minimal-force fractures. Tumor-induced bone destruction or treatment-related effects (e.g., radiation therapy) may also contribute to the weakened bone.

Risk Factors

• History of cancer, particularly with known bone metastasis to the pelvis or femur.
• Advanced-stage malignancies with skeletal involvement.
• Tumors that preferentially affect bone (e.g., multiple myeloma).
• Prior radiation therapy to pelvic or femoral sites.
• Systemic therapies that weaken bone (e.g., certain chemotherapies).

Symptoms

• Sudden onset of pain at the fracture site, often without obvious injury.
• Swelling, bruising, or visible deformity in the affected area.
• Difficulty bearing weight or limited mobility.
• Pain that worsens with movement or pressure.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., X-rays, CT, or MRI), and correlation with the patient’s cancer history. Imaging may reveal bone lesions or fractures in the pelvis or femur, while laboratory tests (e.g., tumor markers) can support the neoplastic cause. Biopsy may be performed to confirm the underlying cancer if not already diagnosed.

Treatment Options

Treatment focuses on stabilizing the fracture, managing pain, and addressing the underlying cancer. Options may include surgical fixation (e.g., plates, rods) to restore bone integrity, radiation therapy to target tumor-related bone destruction, and systemic therapies (e.g., chemotherapy) to control the primary malignancy. Pain management and physical therapy are also integral to recovery.

Prognosis and Follow-Up

Prognosis depends on the extent of the underlying cancer, the fracture’s severity, and treatment response. Regular follow-up with imaging and clinical assessments is essential to monitor healing, detect recurrence, and adjust therapies. Long-term outcomes may be influenced by the cancer’s aggressiveness and the effectiveness of treatment.

Complications

• Delayed or nonunion of the fracture.
• Infection at the fracture site or surgical site.
• Nerve or vascular damage from the fracture or treatment.
• Progression of the underlying cancer.
• Reduced mobility or chronic pain.

Lifestyle & Prevention

• Maintain bone health through adequate nutrition (e.g., calcium, vitamin D) if appropriate.
• Follow prescribed cancer treatments to minimize bone weakening.
• Use assistive devices (e.g., crutches) to avoid weight-bearing stress on the affected area.
• Engage in gentle, guided physical therapy to preserve mobility.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden, severe pain in the pelvis or femur, especially if you have a history of cancer. Symptoms like swelling, deformity, or inability to bear weight warrant prompt evaluation to rule out a pathological fracture.

Tips for Medical Coders

Document the specific anatomical involvement (pelvis and femur) and confirm the fracture is pathological (due to neoplastic disease) rather than traumatic. Ensure the underlying cancer diagnosis and any related treatments are clearly recorded to support code assignment. Verify that no other codes (e.g., for the primary cancer) are omitted if required for complete documentation.